stella
beta
A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC) — Stella
Home
/
Alagille Syndrome (ALGS)
/
A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)
View on ClinicalTrials.gov
Recruiting
Back to Alagille Syndrome (ALGS) trials
A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)
Trial locations
(1 site)
Japan
Takeda selected site, Tokyo, Tokyo